Work

Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies

Year: 2010

Type: article

Source: Transplantation

DOI: 10.1097/tp.0b013e3181ff87cd

Authors: Christian P. Larsen, Josep Grinyó, José Medina-Pestana, Yves Vanrenterghem, Flavio Vincenti, Barbara Breshahan, Josep M. Campistol, Sander Florman, Maria del Carmen Rial, Nassim Kamar, Alan Block, Gregory Di Russo, Chen-Sheng Lin, Pushkal Garg, Bernard Charpentier

Institutions: Emory University, Bellvitge University Hospital, Hospital do Rim e Hipertensão, Universidade Federal de São Paulo, Universitair Ziekenhuis Leuven, University of California, San Francisco, Medical College of Wisconsin, Universitat de Barcelona, Mount Sinai Hospital, Inserm, Hôpital Rangueil, Bristol-Myers Squibb (United States), Bicêtre Hospital

Language: English

Topic: Renal Transplantation Outcomes and Treatments

Subfield: Transplantation

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Bristol-Myers Squibb

OpenAlex ID: W1973505502

FWCI: 17.05

Cites: 22

Cited by: 174

Related to: 10